Comparable results were obtained in a preoperative study on endometrial cancer where p-AMPK levels increased whereas levels of Ki67, p-RPS6, and p-ERK1/2 decreased under MTF treatment [161]. This evidence concerns the gene MKI67 and endometrial cancer.